[go: up one dir, main page]

MXPA06000074A - Composicion que contiene bacterias de acido lactico que producen equol. - Google Patents

Composicion que contiene bacterias de acido lactico que producen equol.

Info

Publication number
MXPA06000074A
MXPA06000074A MXPA06000074A MXPA06000074A MXPA06000074A MX PA06000074 A MXPA06000074 A MX PA06000074A MX PA06000074 A MXPA06000074 A MX PA06000074A MX PA06000074 A MXPA06000074 A MX PA06000074A MX PA06000074 A MXPA06000074 A MX PA06000074A
Authority
MX
Mexico
Prior art keywords
lactic acid
daidzein
acid bacterium
producing equol
composition containing
Prior art date
Application number
MXPA06000074A
Other languages
English (en)
Inventor
Toshimi Suzuki
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MXPA06000074A publication Critical patent/MXPA06000074A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)

Abstract

Se prend prover una composicion bacterias de acido lactico que producen equol caracterizada por contener bacterias de acido lactico que pertenecen al genero Lactococcus que es capaz de metabolizar por lo menos un compuesto de daidzeina seleccionado del grupo que consiste de glicosidos de daidzeina,daidzeina, y dihidrodaidzeina y de esta manera producir equol; y un procedimiento para producir equol caracterizado porque comprende tratar por lo menos un miembro seleccionado del grupo que consiste de compuestos de daidzeina, y materiales que contienen con las bacterias de acido lactico descritas anteriormente. Las bacterias d glicosidos de daidzeina, daidzeina, y dihidrodaidzeina y de esta manera producir equol acido lactico descritas anteriormente incluyen Lactococcus garvieae. Esta composicion es efectiva para prevenir y remediar enfermedades indefinidas que incluyen trastornos de la menopausia en mujeres de edad media y ancianas.
MXPA06000074A 2003-06-30 2004-06-29 Composicion que contiene bacterias de acido lactico que producen equol. MXPA06000074A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003187831 2003-06-30
PCT/JP2004/009484 WO2005000042A1 (ja) 2003-06-30 2004-06-29 エクオール産生乳酸菌含有組成物

Publications (1)

Publication Number Publication Date
MXPA06000074A true MXPA06000074A (es) 2006-03-21

Family

ID=33549734

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000074A MXPA06000074A (es) 2003-06-30 2004-06-29 Composicion que contiene bacterias de acido lactico que producen equol.

Country Status (21)

Country Link
US (3) US8765445B2 (es)
EP (2) EP2548455B1 (es)
JP (1) JP3864317B2 (es)
KR (2) KR101043465B1 (es)
CN (1) CN1826059B (es)
AR (1) AR044953A1 (es)
AU (1) AU2004251563B2 (es)
BR (1) BRPI0412180B1 (es)
CA (1) CA2531173C (es)
CY (2) CY1114248T1 (es)
DK (2) DK1649760T3 (es)
ES (2) ES2417481T3 (es)
HU (1) HUE030615T2 (es)
MX (1) MXPA06000074A (es)
MY (1) MY146563A (es)
PL (2) PL1649760T3 (es)
PT (2) PT1649760E (es)
SG (1) SG157232A1 (es)
SI (2) SI1649760T1 (es)
TW (2) TW201118175A (es)
WO (1) WO2005000042A1 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG157232A1 (en) * 2003-06-30 2009-12-29 Otsuka Pharma Co Ltd Equol-producing lactic acid bacteria-containing composition
JP4811760B2 (ja) * 2004-12-27 2011-11-09 独立行政法人農業・食品産業技術総合研究機構 ダイゼイン資化によるエコール生成能を改善するための腸内細菌およびその利用
CA2628803C (en) * 2005-11-02 2016-07-05 Kabushiki Kaisha Yakult Honsha Equol level regulator
CN102726683B (zh) 2005-12-06 2015-04-01 大塚制药株式会社 含雌马酚的大豆胚轴发酵物
JP2007308428A (ja) * 2006-05-19 2007-11-29 Fancl Corp 摂食抑制剤
JP5122766B2 (ja) * 2006-06-20 2013-01-16 ユニチカ株式会社 エコール産生促進組成物
JP5517613B2 (ja) * 2007-05-28 2014-06-11 不二製油株式会社 エクオール非産生者用の血中エクオール産生促進組成物
AU2013203101B2 (en) * 2007-06-13 2015-07-09 Otsuka Pharmaceutical Co., Ltd. Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
CN102934774B (zh) * 2007-06-13 2014-03-05 大塚制药株式会社 含雌马酚的提取物、其制备方法、雌马酚的提取方法及含雌马酚的食品
CN101868152A (zh) * 2007-11-23 2010-10-20 荷兰联合利华有限公司 发酵的大豆基饮料
KR20130133894A (ko) * 2007-12-27 2013-12-09 오츠카 세이야쿠 가부시키가이샤 에쿠올 합성에 관여하는 효소
JP2009232712A (ja) * 2008-03-26 2009-10-15 Glico Dairy Products Co Ltd エクオール産生組成物，エクオール産生方法及びエクオール含有組成物
KR101600867B1 (ko) * 2008-06-03 2016-03-10 삼성전자주식회사 냉장고
AU2014240200B2 (en) * 2008-09-19 2015-08-13 Otsuka Pharmaceutical Co., Ltd. Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
CN102159092B (zh) * 2008-09-19 2016-03-16 大塚制药株式会社 含有维持了雌马酚产生能力的雌马酚产生微生物的发酵制品及其制备方法
CA2753103C (en) 2009-02-25 2017-09-12 Kabushiki Kaisha Yakult Honsha Equol-producing bacterium and use thereof
JP2011036190A (ja) * 2009-08-12 2011-02-24 Enseki Aojiru Kk 顆粒状経口食品の製造方法及びその顆粒状経口食品
JP5777287B2 (ja) * 2009-09-18 2015-09-09 大塚製薬株式会社 エクオール産生能が維持されたエクオール産生微生物を含む発酵製品、及びその製造方法
KR101024297B1 (ko) * 2010-08-11 2011-03-29 유익종 유산 발효에 의해 계란단백질의 항원성이 저하된 유산발효계란 및 그의 제조방법
CN102021130A (zh) * 2010-10-21 2011-04-20 南京农业大学 一株降解大豆苷原产生雌马酚的双酶梭菌及其菌剂和应用
US20120251511A1 (en) * 2011-03-28 2012-10-04 Eric Donald Murphy Composition and products for enabling the production of equol in vivo
NL2008294C2 (en) * 2011-05-20 2013-08-19 Friesland Brands Bv Food composition comprising vitamin k and saturated fat.
ITMI20111829A1 (it) * 2011-10-07 2013-04-08 Paladin Pharma S P A Procedimento per la preparazione di una composizione a base di equolo
KR101307947B1 (ko) * 2011-11-30 2013-09-12 씨제이제일제당 (주) 싸이코스를 유효성분으로 하는 에쿠올 농도 상승제
JP5996187B2 (ja) * 2011-12-20 2016-09-21 株式会社ダイセル エクオールの製造方法
JP6201982B2 (ja) * 2012-03-30 2017-09-27 味の素株式会社 糖尿病誘起細菌
CN104087532B (zh) * 2014-07-04 2016-04-20 浙江省农业科学院 一种来源于鸡肠道的雌马酚产生梭菌c1-6及应用
KR102064055B1 (ko) * 2018-02-08 2020-01-08 신선옥 에쿠올이 생성된 발효커피생두, 그 제조방법 및 그 추출물
JP2018186823A (ja) * 2018-07-13 2018-11-29 株式会社ダイセル イソフラバノン類の製造方法
WO2020210194A1 (en) * 2019-04-08 2020-10-15 Corn Products Development, Inc. Improved plant-protein based analog dairy compositions
WO2020210547A1 (en) * 2019-04-09 2020-10-15 Martin Munzer Protein substitute amino acid compositions and products, and other food and beverage products
US11730778B2 (en) * 2019-09-24 2023-08-22 Access Business Group International Llc Method of increasing the level and production of metabolized phytonutrients in a subject
KR20230013255A (ko) * 2020-05-21 2023-01-26 주식회사 다이셀 폐경 후에 갱년기 장애를 가지지 않는 만 40세 이상의 여성을 위한 qol 개선용 조성물
CN114150030B (zh) * 2021-12-24 2024-05-14 内蒙古金达威药业有限公司 一种透明质酸的生产方法
WO2023224086A1 (ja) * 2022-05-19 2023-11-23 株式会社ダイセル エクオールを含む食品組成物およびその製造方法
WO2025099959A1 (ja) * 2023-11-09 2025-05-15 株式会社ダイセル 組成物の製造方法、飲食品の製造方法及び発酵組成物
JP7484031B1 (ja) 2023-11-09 2024-05-15 株式会社ダイセル 組成物の製造方法及び飲食品の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2249837T3 (es) * 1997-08-08 2006-04-01 Otsuka Pharmaceutical Co., Ltd. Composiciones que contienen isoflavona.
US7396855B2 (en) * 2002-07-24 2008-07-08 Children's Hospital Medical Center Compositions and products containing S-equol, and methods for their making
JP2003081855A (ja) 2002-08-19 2003-03-19 Yakult Honsha Co Ltd 脂質代謝改善剤およびそれを含有する食品
AU2003286781B2 (en) * 2002-10-29 2009-05-21 Brigham Young University Use of equol for treating androgen mediated diseases
SG157232A1 (en) * 2003-06-30 2009-12-29 Otsuka Pharma Co Ltd Equol-producing lactic acid bacteria-containing composition

Also Published As

Publication number Publication date
ES2417481T3 (es) 2013-08-08
EP2548455B1 (en) 2016-08-31
KR20060028436A (ko) 2006-03-29
US20190038684A1 (en) 2019-02-07
KR101054631B1 (ko) 2011-08-04
TW201118175A (en) 2011-06-01
PT1649760E (pt) 2013-06-25
MY146563A (en) 2012-08-30
US8765445B2 (en) 2014-07-01
JP3864317B2 (ja) 2006-12-27
AR044953A1 (es) 2005-10-12
SI1649760T1 (sl) 2013-07-31
PT2548455T (pt) 2016-11-09
DK1649760T3 (da) 2013-07-08
ES2601885T3 (es) 2017-02-16
TWI335353B (en) 2011-01-01
CY1114248T1 (el) 2016-08-31
HK1090812A1 (en) 2007-01-05
SG157232A1 (en) 2009-12-29
EP1649760A4 (en) 2008-06-25
KR101043465B1 (ko) 2011-06-23
US10098915B2 (en) 2018-10-16
US20060148045A1 (en) 2006-07-06
WO2005000042A1 (ja) 2005-01-06
US20140050703A1 (en) 2014-02-20
EP2548455A1 (en) 2013-01-23
BRPI0412180A (pt) 2006-08-22
KR20110044810A (ko) 2011-04-29
CN1826059B (zh) 2011-09-28
HUE030615T2 (en) 2017-05-29
BRPI0412180B1 (pt) 2014-06-17
CA2531173A1 (en) 2005-01-06
JPWO2005000042A1 (ja) 2006-07-27
DK2548455T3 (en) 2016-11-28
CA2531173C (en) 2013-09-10
EP1649760B1 (en) 2013-05-22
SI2548455T1 (sl) 2016-11-30
TW200510542A (en) 2005-03-16
CY1118534T1 (el) 2017-07-12
PL1649760T3 (pl) 2013-10-31
CN1826059A (zh) 2006-08-30
AU2004251563B2 (en) 2009-04-23
AU2004251563A1 (en) 2005-01-06
EP1649760A1 (en) 2006-04-26
PL2548455T3 (pl) 2017-03-31

Similar Documents

Publication Publication Date Title
MXPA06000074A (es) Composicion que contiene bacterias de acido lactico que producen equol.
IL144297A0 (en) Composition for treating obesity and aesthetic treatment method
WO2001052921A3 (en) Valve arrangement
KR100352030B1 (en) Gum composition for removing nicotine
AR057220A1 (es) Hipocotilo de soja fermentado que contiene equol y metodo para producir el mismo
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
WO2002036106A3 (de) Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
TR200002770T2 (tr) Estrojene bağlı bozuklukların tedavisi
AU2002236795A1 (en) Compositions and method of tissue superoxygenation
WO2002026727A3 (en) Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai
WO2001015715A3 (en) Composition for maintenance of bone or dental health or treatment of bone or dental disorders
WO2005030120A3 (en) Antiangiogenic agents
ZA200500715B (en) Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
CA2518971A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
WO2006023496A3 (en) Vaginal cream compositions, kits thereof and methods of using thereof
AU2003239793A8 (en) Alicyclic esters having a musky smell
WO2002042319A3 (en) 2-substituted estrogens as antiangiogenic agents
EP1669080A4 (en) METHOD FOR INHIBITING ALVEOLARY RESORPTION AND PERIODENTAL MEMBRANE LOSS AND COMPOSITION FOR INNER APPLICATION THEREOF
MXPA03001356A (es) Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos.
MXPA05011193A (es) Compuestos iniciales para producir poliuretanos.
WO2006128089A3 (en) Compositions and methods for treating tissue
WO2002070638A3 (en) Essential oil from.coleus forskohlii, production process and use as antimicrobial agent
MXPA03007071A (es) Aminaldionas como abridores del canal de potasio.
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
UA58609U (ru) Способ приготовления водки

Legal Events

Date Code Title Description
FG Grant or registration